Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia.

Aisling R CaffreyTristan T TimbrookSyed Raza AliVictor NizetGeorge Sakoulas

Published in: Therapeutic advances in gastroenterology (2019)

In our large national cohort study, PPIs were not associated with an increased risk of negative clinical outcomes, including mortality and CDI, in patients with S. aureus bacteremia.

Keyphrases

staphylococcus aureus
gram negative
cardiovascular events
risk factors
biofilm formation
type diabetes
multidrug resistant
pseudomonas aeruginosa
methicillin resistant staphylococcus aureus
cystic fibrosis